Reaction
Mouth Injury reporting signals
As of the last recalculation, Mouth Injury appears in 1,505 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is EMICIZUMAB (PRR 31.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Emicizumab | 28 | 31.9 | 32.0 |
| Sunitinib Malate | 79 | 29.3 | 29.3 |
| Efavirenz | 17 | 21.3 | 21.3 |
| Ribociclib | 26 | 11.6 | 11.6 |
| Everolimus | 40 | 11.1 | 11.1 |
| Cenobamate | 5 | 8.3 | 8.3 |
| Panitumumab | 9 | 8.0 | 8.0 |
| Tapentadol Hydrochloride | 18 | 7.5 | 7.5 |
| Nicotine Polacrilex | 20 | 7.3 | 7.3 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 4 | 6.4 | 6.4 |
| Nicotine | 16 | 5.5 | 5.5 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 9 | 5.2 | 5.2 |
| Alpelisib | 3 | 4.8 | 4.8 |
| Palbociclib | 30 | 4.4 | 4.4 |
| Voxelotor | 4 | 2.5 | 2.5 |